Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the ethics commission of the French society of hematology.
Malak S, Sotto JJ, Ceccaldi J, Colombat P, Casassus P, Jaulmes D, Rochant H, Cheminant M, Beaussant Y, Zittoun R, Bordessoule D. Malak S, et al. Among authors: rochant h. Adv Hematol. 2014;2014:704318. doi: 10.1155/2014/704318. Epub 2014 Oct 1. Adv Hematol. 2014. PMID: 25349612 Free PMC article. Review.
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group.
Guilhot F, Guerci A, Fiere D, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Rochant H, Najman A, Nicolini F, Colombat P, Abgrall JF, Ifrah N, Brière J, Bauters F, Navarro M, Morice P, Bordessoule D, Vilque JP, Desablens B, Tertian G, Blanc M, Chastang C, Tanzer J. Guilhot F, et al. Among authors: rochant h. Bone Marrow Transplant. 1996 May;17 Suppl 3:S29-31. Bone Marrow Transplant. 1996. PMID: 8769697 Clinical Trial. No abstract available.
A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results.
Guilhot F, Lamagnère JP, Harousseau JL, Tilly H, Casassus P, Ifrah N, Rochant H, Bauters F, Dine G, Tanzer J. Guilhot F, et al. Among authors: rochant h. Eur J Cancer. 1991;27 Suppl 4:S26. doi: 10.1016/0277-5379(91)90561-q. Eur J Cancer. 1991. PMID: 1799470 Clinical Trial. No abstract available.
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes.
Wattel E, Solary E, Leleu X, Dreyfus F, Brion A, Jouet JP, Hoang-Ngoc L, Maloisel F, Guerci A, Rochant H, Gratecos N, Casassus P, Janvier M, Brice P, Lepelley P, Fenaux P. Wattel E, et al. Among authors: rochant h. Leukemia. 1999 Apr;13(4):524-9. doi: 10.1038/sj.leu.2401387. Leukemia. 1999. PMID: 10214857 Clinical Trial.
[Lactic acidosis during acute leukemia].
Marty M, Vernant JP, Rochant H, Tulliez M, Brun B, Dreyfus B. Marty M, et al. Among authors: rochant h. Ann Med Interne (Paris). 1975 Feb;126(2):115-20. Ann Med Interne (Paris). 1975. PMID: 1065251 French. No abstract available.
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic results.
Guilhot F, Abgrall JF, Harousseau JL, Bauters F, Brice P, Dine G, Tilly H, Ifrah N, Cassasus P, Rochant H, et al. Guilhot F, et al. Among authors: rochant h. Leuk Lymphoma. 1993;11 Suppl 1:181-3. doi: 10.3109/10428199309047883. Leuk Lymphoma. 1993. PMID: 8251893 Clinical Trial.
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.
Wattel E, Solary E, Hecquet B, Caillot D, Ifrah N, Brion A, Mahé B, Milpied N, Janvier M, Guerci A, Rochant H, Cordonnier C, Dreyfus F, Buzyn A, Hoang-Ngoc L, Stoppa AM, Gratecos N, Sadoun A, Stamatoulas A, Tilly H, Brice P, Maloisel F, Lioure B, Desablens B, Fenaux P, et al. Wattel E, et al. Among authors: rochant h. Br J Haematol. 1998 Sep;102(4):1015-24. doi: 10.1046/j.1365-2141.1998.00870.x. Br J Haematol. 1998. PMID: 9734653 Free article. Clinical Trial.
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.
Wattel E, Solary E, Hecquet B, Caillot D, Ifrah N, Brion A, Milpied N, Janvier M, Guerci A, Rochant H, Cordonnier C, Dreyfus F, Veil A, Hoang-Ngoc L, Stoppa AM, Gratecos N, Sadoun A, Tilly H, Brice P, Lioure B, Desablens B, Pignon B, Abgrall JP, Leporrier M, Fenaux P, et al. Wattel E, et al. Among authors: rochant h. Adv Exp Med Biol. 1999;457:35-46. doi: 10.1007/978-1-4615-4811-9_5. Adv Exp Med Biol. 1999. PMID: 10500778 Clinical Trial.
140 results